Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
OPRX

OPRX - OptimizeRx Corp Stock Price, Fair Value and News

$6.40+0.47 (+7.93%)
Delayed

69/100

OPRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

69/100

OPRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

OPRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OPRX Price Action

Last 7 days

-5.0%

Last 30 days

-30.7%

Last 90 days

-52.1%

Trailing 12 Months

-10.5%

OPRX RSI Chart

OPRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OPRX Valuation

Market Cap

120.1M

Price/Earnings (Trailing)

23.4

Price/Sales (Trailing)

1.1

EV/EBITDA

7.96

Price/Free Cashflow

6.44

OPRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

OPRX Fundamentals

OPRX Revenue

Revenue (TTM)

109.4M

Rev. Growth (Yr)

-0.24%

Rev. Growth (Qtr)

23.68%

OPRX Earnings

Earnings (TTM)

5.1M

Earnings Growth (Yr)

6.5K%

Earnings Growth (Qtr)

544.42%

OPRX Profitability

Operating Margin

67.25%

EBT Margin

6.35%

Return on Equity

4%

Return on Assets

2.9%

Free Cashflow Yield

15.54%

OPRX Investor Care

Shares Dilution (1Y)

1.47%

Diluted EPS (TTM)

0.27

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202594.4M104.7M109.5M109.4M
202478.2M83.2M88.2M92.1M
202361.7M61.6M62.8M71.5M
202263.8M64.1M63.1M62.5M
202147.0M51.8M57.4M61.3M
202027.0M28.8M34.3M43.3M
201922.3M24.2M23.8M24.6M
201814.1M16.3M18.6M21.2M
20178.1M9.1M10.4M12.1M
20167.5M7.7M7.5M7.8M
20156.7M7.0M7.2M7.2M
20145.3M5.6M6.2M6.5M
20132.3M2.9M3.7M4.7M
20121.0M1.4M1.6M2.0M
2011331.2K591.3K851.4K1.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About OptimizeRx Corp

OPRX
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
 CEO
 WEBSITEoptimizerx.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES109

OptimizeRx Corp Frequently Asked Questions

OPRX is the stock ticker symbol of OptimizeRx Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of OptimizeRx Corp is 120.08 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, OPRX's PE ratio (Price to Earnings) is 23.4 and Price to Sales (PS) ratio is 1.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OPRX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, OptimizeRx Corp has provided 0.083 (multiply by 100 for percentage) rate of return.